BOLT · Bolt Biotherapeutics Inc
United States · RS rating 95 · As of 2026-11-03
| Price | 6.57 USD |
|---|---|
| 1-day change | +5.3% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 99 / 96 / 63 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 42 / 47 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -3.2% |
| Sales growth Q/Q | +15.3% |
| Distance from 52-week high | +7.3% |
| Market cap (USD) | $9.2M |